Adicet Bio, Inc. — Director's Dealing 2025

Feb 4, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Adicet Bio, Inc. (ACET)
CIK: 0001720580
Period of Report: 2025-01-31

Reporting Person: Maltzman Julia D. (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-01-31	Stock Option (Right to Buy)	$0.885	A	750000	Acquired	2035-01-30	Common Stock (750000)	Direct

Footnotes

F1: 25% of the shares subject to the stock option shall vest on December 7, 2025, and the remainder of the shares shall vest in equal monthly installments for a period of 36 months thereafter, provided that the Reporting Person maintains a service relationship with the Issuer as of the applicable vesting dates.